CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,923,078
- in 11 filings, $11.2M under 10b5-1 plans
Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Satchi-Fainaro Ronit Director | Option exercise · Restricted Share Units | −14,492 | 0 | ||
| 2026-06-05 | Zaks Tal Zvi Director | Option exercise | +14,492 | 73,264 | ||
| 2026-06-05 | Zaks Tal Zvi Director | Option exercise · Restricted Share Units | −14,492 | 0 | ||
| 2026-06-05 | MIGNONE ROBERTO Director | Option exercise | +14,492 | 119,807 | ||
| 2026-06-05 | MIGNONE ROBERTO Director | Option exercise · Restricted Share Units | −14,492 | 0 | ||
| 2026-06-05 | Francis Richard D President and CEO | Option exercise 10b5-1 | +13,043 | 1,183,682 | ||
| 2026-06-05 | Francis Richard D President and CEO | Sale 10b5-1 | −6,153 | $34.35 | $211K | 1,177,529 |
| 2026-06-05 | Francis Richard D President and CEO | Option exercise · Restricted Share Units 10b5-1 | −13,043 | 39,130 | ||
| 2026-06-03 | Shields Matthew EVP, Global Operations | Option exercise 10b5-1 | +16,195 | 26,184 | ||
| 2026-06-03 | Shields Matthew EVP, Global Operations | Sale 10b5-1 | −16,195 | $32.87 | $532K | 9,989 |
| 2026-06-03 | Shields Matthew EVP, Global Operations | Option exercise · Restricted Share Units 10b5-1 | −16,195 | 32,392 | ||
| 2026-05-28 | Zaks Tal Zvi Director | Grant or award · Restricted Share Units | +7,242 | 7,242 | ||
| 2026-05-28 | Satchi-Fainaro Ronit Director | Grant or award · Restricted Share Units | +7,242 | 7,242 | ||
| 2026-05-28 | Nisen Perry Director | Grant or award · Restricted Share Units | +7,242 | 7,242 | ||
| 2026-05-28 | LIEBERMAN GERALD M Director | Grant or award · Restricted Share Units | +7,242 | 7,242 | ||
| 2026-05-28 | Elstein Amir Director | Grant or award · Restricted Share Units | +7,242 | 7,242 | ||
| 2026-05-28 | Crane Rosemary A Director | Grant or award · Restricted Share Units | +7,242 | 7,242 | ||
| 2026-05-28 | Lichtenstein Chen Director | Grant or award · Restricted Share Units | +7,242 | 7,242 | ||
| 2026-05-28 | BARER SOL J Director | Grant or award · Restricted Share Units | +10,863 | 10,863 | ||
| 2026-05-28 | MIGNONE ROBERTO Director | Grant or award · Restricted Share Units | +7,242 | 7,242 |
Page 4 of 64 · 1,279 trades